What Zavesca contains
The active substance is miglustat 100 mg.
Other ingredients in the capsule are:
Sodium starch glycollate,
Povidone (K30),
Magnesium stearate.
Other ingredients in the capsule shell are:
Gelatin,
Water,
Titanium dioxide (E171).
Other ingredients in the Printing ink are:
Black iron oxide (E172)
Shellac.
What Zavesca looks like and contents of the pack
Zavesca is a white 100 mg capsule with ?OGT 918? printed in black on the cap and ?100? printed in black on the body.
Box of 4 blister strips, each blister strip containing 21 capsules providing a total of 84 capsules.
Marketing Authorisation Holder:
Actelion Registration Ltd
BSI Building 13 th Floor
389 Chiswick High Road
London W4 4AL
United Kingdom
Manufacturer responsible for batch release:
Actelion Pharmaceuticals Deutschland GmbH
Basler Strasse 63?65
79100 Freiburg
Germany
For any information about this medicine, please contact the local representative of the Marketing Authorisation Holder.
BelgiëBelgiqueBelgien Actelion Pharmaceuticals Belgium N.V. TélTel 32-015 284 777 LuxembourgLuxemburg Actelion Pharmaceuticals Belgium N.V. TélTel 32-015 284 777
Actelion Pharmaceuticals Ltd Te. 420-2 3413 8150 Magyarország Actelion Pharmaceuticals Ltd Tel 48 0 500 145 920
eská republika Actelion Pharmaceuticals CZ, s.r.o. Tel 420 2 21 968 006 Malta Actelion Pharmaceuticals Ltd Tel 48 0 500 145 920
Danmark Actelion Pharmaceuticals Sverige AB Tlf 46-08 544 982 50 Nederland Actelion Pharmaceuticals Nederland B.V. Tel 31-0348 435950
Deutschland Actelion Pharmaceuticals Deutschland GmbH Tel 49-0761 45 64 0 Norge Actelion Pharmaceuticals Sverige AB Tlf 46-08 544 982 50
Eesti Nycomed SEFA AS Tel 372 6112 569 Österreich Actelion Pharmaceuticals Austria GmbH Tel 43-01 505 4527
Actelion Pharmaceuticals E .. 30 210 675 25 00 Polska Actelion Pharma Polska Sp. z o.o. Tel 48 0 500 145 920
España Actelion Pharmaceuticals España S.L. Tel 34 93 253 10 64 Portugal Actelion Pharmaceuticals Portugal Lda. Tel 351 21 358 6120
France Actelion Pharmaceuticals France SAS Tél 33-01 58 62 32 32 România Geneva Romfarm Internacional Tel 40 021 231 3561
Ireland Actelion Pharmaceuticals UK Ltd Tel 353 1890 771 648 Slovenija Medis d.o.o. Tel 386-01 589 69 00
Ísland Actelion Pharmaceuticals Sverige AB Sími 46-08 544 982 50 Slovenská republika Actelion Pharmaceuticals SK, s.r.o. Tel 420 2 21 968 006
Italia Actelion Pharmaceuticals Italia S.r.l. Tel 39 0542 64 87 40 SuomiFinland Actelion Pharmaceuticals Sverige AB PuhTel 46-08 544 982 50
Actelion Pharmaceuticals E .. 30 210 675 25 00 Sverige Actelion Pharmaceuticals Sverige AB Tel 46-08 544 982 50
Latvija Nycomed Latvija Tel 371 784 0082 United Kingdom Actelion Pharmaceuticals UK Ltd Tel 44-0845 075 0555
Lietuva
Nycomed atstovyb-
Tel: +370 5210 9070
This leaflet was last approved in:
This medicine has been authorised under ?Exceptional Circumstances?. This means that because of the rarity of this disease it has been impossible to get complete information on this medicine. The European Medicines Agency will review any new information on the medicine every year and this leaflet will be updated as necessary.